Literature DB >> 20944753

One hundred human pancreatic islet isolations at Baylor Research Institute.

Morihito Takita1, Shinichi Matsumoto, Hirofumi Noguchi, Masayuki Shimoda, Daisuke Chujo, Koji Sugimoto, Takeshi Itoh, Jeffrey P Lamont, Luis F Lara, Nicholas Onaca, Bashoo Naziruddin, Goran B Klintmalm, Marlon F Levy.   

Abstract

The effectiveness of pancreatic islet isolation must be maximized to make islet cell transplantation (ICT) a standard therapy. We have performed 100 human islet isolations at Baylor Research Institute including islet isolations for research, for clinical allogeneic transplantation, and for autologous islet transplantation. In this study, we analyzed the results of these isolations. First, we assessed 79 islet isolations using brain-dead donors to determine variables associated with successful islet isolation. Univariate logistic regression analysis revealed that seven variables influenced the success of islet isolation for allogeneic ICT: cause of death, mechanism of death, techniques for pancreas procurement and preservation, heavy fatty infiltration, collagenase type, dilution time, and islet purification method. Multivariate regression analysis revealed that only the current isolation protocol, the Baylor Islet Isolation Method (BIIM)-with its four required elements of pancreas procurement by the team, pancreatic ductal injection, the two-layer method with perfluorocarbon, and density-adjusted density gradient purification-had a significant positive impact on successful islet isolation (P = 0.02). Second, we compared allogeneic and autologous ICT using the BIIM. There were no significant differences in islet yields between allogeneic and autologous ICT using the BIIM; total islet yield after purification was 628 ± 84 × 10(3) IE in allogeneic ICT vs. 576 ± 49 × 10(3) IE in autologous ICT (P = 0.59). This retrospective study revealed that the BIIM provided favorable outcomes for both autologous and allogeneic ICT.

Entities:  

Year:  2010        PMID: 20944753      PMCID: PMC2943445          DOI: 10.1080/08998280.2010.11928648

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  35 in total

1.  Interests in beta-cell replacement therapies among Japanese patients with type 1 diabetes.

Authors:  Nobuyo Hatanaka; Morihito Takita; Takuhiro Yamaguchi; Masahiro Kami; Shinichi Matsumoto
Journal:  Diabetes Res Clin Pract       Date:  2010-05-04       Impact factor: 5.602

2.  Kyoto islet isolation method: the optimized one for non-heart-beating donors with highly efficient islet retrieval.

Authors:  T Okitsu; S Matsumoto; Y Iwanaga; H Noguchi; H Nagata; Y Yonekawa; T Maekawa; K Tanaka
Journal:  Transplant Proc       Date:  2005-10       Impact factor: 1.066

3.  Pancreatic islet cell transplantation using non-heart-beating donors (NHBDs).

Authors:  Shinichi Matsumoto; Koichi Tanaka
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

4.  Simplified calculation of body-surface area.

Authors:  R D Mosteller
Journal:  N Engl J Med       Date:  1987-10-22       Impact factor: 91.245

5.  Variables in organ donors that affect the recovery of human islets of Langerhans.

Authors:  J R Lakey; G L Warnock; R V Rajotte; M E Suarez-Alamazor; Z Ao; A M Shapiro; N M Kneteman
Journal:  Transplantation       Date:  1996-04-15       Impact factor: 4.939

6.  International trial of the Edmonton protocol for islet transplantation.

Authors:  A M James Shapiro; Camillo Ricordi; Bernhard J Hering; Hugh Auchincloss; Robert Lindblad; R Paul Robertson; Antonio Secchi; Mathias D Brendel; Thierry Berney; Daniel C Brennan; Enrico Cagliero; Rodolfo Alejandro; Edmond A Ryan; Barbara DiMercurio; Philippe Morel; Kenneth S Polonsky; Jo-Anna Reems; Reinhard G Bretzel; Federico Bertuzzi; Tatiana Froud; Raja Kandaswamy; David E R Sutherland; George Eisenbarth; Miriam Segal; Jutta Preiksaitis; Gregory S Korbutt; Franca B Barton; Lisa Viviano; Vicki Seyfert-Margolis; Jeffrey Bluestone; Jonathan R T Lakey
Journal:  N Engl J Med       Date:  2006-09-28       Impact factor: 91.245

7.  Multicenter analysis of novel and established variables associated with successful human islet isolation outcomes.

Authors:  J S Kaddis; J S Danobeitia; J C Niland; T Stiller; L A Fernandez
Journal:  Am J Transplant       Date:  2010-01-05       Impact factor: 8.086

Review 8.  Point: steady progress and current challenges in clinical islet transplantation.

Authors:  Davide Mineo; Antonello Pileggi; Rodolfo Alejandro; Camillo Ricordi
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

9.  The rationale for the new deceased donor pancreas allocation schema.

Authors:  Mark D Stegall; Patrick G Dean; Randall Sung; Mary K Guidinger; Maureen A McBride; Cindy Sommers; Giacomo Basadonna; Peter G Stock; Alan B Leichtman
Journal:  Transplantation       Date:  2007-05-15       Impact factor: 4.939

Review 10.  The clinical impact of islet transplantation.

Authors:  P Fiorina; A M J Shapiro; C Ricordi; A Secchi
Journal:  Am J Transplant       Date:  2008-10       Impact factor: 8.086

View more
  9 in total

1.  Impact of tissue volume and purification on clinical autologous islet transplantation for the treatment of chronic pancreatitis.

Authors:  Shinichi Matsumoto; Morihito Takita; Masayuki Shimoda; Koji Sugimoto; Takeshi Itoh; Daisuke Chujo; Jeffery A SoRelle; Yoshiko Tamura; Ana M Rahman; Nicholas Onaca; Bashoo Naziruddin; Marlon F Levy
Journal:  Cell Transplant       Date:  2012-02-02       Impact factor: 4.064

Review 2.  SUITO index for evaluation of clinical islet transplantation.

Authors:  Morihito Takita; Shinichi Matusmoto
Journal:  Cell Transplant       Date:  2012       Impact factor: 4.064

3.  Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation.

Authors:  J A SoRelle; T Itoh; H Peng; M A Kanak; K Sugimoto; S Matsumoto; M F Levy; M C Lawrence; B Naziruddin
Journal:  Diabetologia       Date:  2013-01-15       Impact factor: 10.122

4.  Pancreatic ductal perfusion at organ procurement enhances islet yield in human islet isolation.

Authors:  Morihito Takita; Takeshi Itoh; Masayuki Shimoda; Mazhar A Kanak; Rauf Shahbazov; Faisal Kunnathodi; Michael C Lawrence; Bashoo Naziruddin; Marlon F Levy
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

5.  Clinical allogeneic and autologous islet cell transplantation: update.

Authors:  Shinichi Matsumoto
Journal:  Diabetes Metab J       Date:  2011-06-30       Impact factor: 5.376

6.  Pilot study: deficiency of mannose-binding lectin-dependent lectin pathway, a novel modulator in outcome from pancreatic islet auto-transplantation.

Authors:  Wen Yuan Chung; Cristina A Pollard; Cordula Stover; Bashoo Naziruddin; Rohan Kumar; John Isherwood; Eyad Issa; Marlon F Levy; Giuseppe Garcea; Ashley R Dennison
Journal:  Ann Transl Med       Date:  2020-03

7.  A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation.

Authors:  Wen Yuan Chung; Cristina A Pollard; Rohan Kumar; Christopher J Drogemuller; Bashoo Naziruddin; Cordula Stover; Eyad Issa; John Isherwood; Jill Cooke; Marlon F Levy; P Toby H Coates; Giuseppe Garcea; Ashley R Dennison
Journal:  Ann Transl Med       Date:  2021-01

8.  Assessment of Culture/Preservation Conditions of Human Islets for Transplantation.

Authors:  Yoshitaro Shindo; Jagan Kalivarathan; Prathab Balaji Saravanan; Marlon F Levy; Mazhar A Kanak
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.064

9.  Ductal injection does not increase the islet yield or function after cold storage in a vascular perfusion model.

Authors:  Wataru Nakanishi; Takehiro Imura; Akiko Inagaki; Yasuhiro Nakamura; Satoshi Sekiguchi; Keisei Fujimori; Susumu Satomi; Masafumi Goto
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.